AJR ARRS Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khalili, K.
Right arrow Articles by Wanless, I. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khalili, K.
Right arrow Articles by Wanless, I. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2003; 180:1601-1604
© American Roentgen Ray Society


Original Report

Hepatic Subcapsular Steatosis in Response to Intraperitoneal Insulin Delivery: CT Findings and Prevalence

Korosh Khalili1,2, Frederick P. Lan1, Anthony E. Hanbidge1, Derek Muradali1, Dmitrios G. Oreopoulos3 and Ian R. Wanless4

1 Department of Medical Imaging, University Health Network and Mount Sinai Hospitals, 200 Elizabeth St., Toronto, Ontario M4G 2C4, Canada.
2 Department of Medical Imaging, 3-964, Princess Margaret Hospital, University Health Network, 610 University Ave., Toronto, Ontario M5G 2M9, Canada.
3 Department of Internal Medicine, University Health Network and Mount Sinai Hospitals, Toronto, Ontario M4G 2C4, Canada.
4 Department of Laboratory Medicine and Pathobiology, University Health Network and Mount Sinai Hospitals, Toronto, Ontario M4G 2C4, Canada.

OBJECTIVE. The aim of this study was to investigate the CT findings and prevalence of hepatic subcapsular steatosis in patients undergoing peritoneal dialysis with intraperitoneal insulin delivery.

CONCLUSION. Hepatic subcapsular steatosis appeared as subcapsular nodules and often rindlike areas of low attenuation in seven (18%) of 39 patients who received intraperitoneal insulin with their peritoneal dialysate. Cessation of intraperitoneal insulin therapy led to reversal of the steatosis in three patients.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. Demir, D. Torun, N. Tokmak, U. Ozkan, and L. Oguzkurt
Resolution of hepatic subcapsular steatosis after discontinuation of CAPD
Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1247 - 1249.
[Full Text] [PDF]


Home page
RadioGraphicsHome page
O. W. Hamer, D. A. Aguirre, G. Casola, J. E. Lavine, M. Woenckhaus, and C. B. Sirlin
Fatty Liver: Imaging Patterns and Pitfalls
RadioGraphics, November 1, 2006; 26(6): 1637 - 1653.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Roentgen Ray Society.